Interim report
Page 1
ContextVision CONTEXTVISION AB SECOND QUARTER 2021 Q2 HIGHLIGHTS ● Highest Q2 sales ever ● Progress with clinical evaluations within Digital Pathology Cash position further strengthened by positive cash flow Operating margin within core business Medical Imaging 42 % Q2 FINANCIAL DATA Sales of 24.4 MSEK ( 20.1 ) ● ● Operating result of -3.0 MSEK ( 1.6 ) and operating margin of -12.3 % ( 7.9 % ) ● Earnings per share of -0.03 SEK ( 0.02 * ) EBITDA of -0.1 MSEK ( 3.7 ) * The earnings per share have been re - calculated for the comparison period due to a share split in August 2020 . 3D 4D H ( 17 ) उ ہار O